To provide a direct answer: No, cagrilintide is not a GLP-1 (Glucagon-Like Peptide-1). While both are used in the context of metabolic research and weight management, cagrilintide belongs to a completely different class of molecules. GLP-1 is an incretin hormone,…
Cagrilintide is a long‑acting amylin analogue (not a GIP/GLP‑1 receptor agonist) that is being studied both alone and in fixed‑dose combination with the GLP‑1 agonist semaglutide—a pairing known as CagriSema—for obesity and type 2 diabetes. In the phase 3 REDEFINE…
All products on this website are sold strictly for in vitro research and laboratory use only.
By clicking "Accept," you confirm:
